Colorectal cancer patients (n = 8) with shorter survival and poorer prognosis exerted a lower immunoreactivity of GalR3 compared to higher expression of this protein in non-cancerous epithelial cells (Figure 6A2,B2). The gene discussed is GALR3; the disease is colorectal cancer.